Stephanie Crosby
Women's Health · Laurel, MSNPI 1447299508
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $732 and has fallen 71.7% since, to $208 in 2025.
Across 110 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$385
- AbbVie$270
- Astellas Pharma US Inc$120
- Novartis$110
- Lilly USA, LLC$101
- Hologic Sales And Service, LLC$76
- plus $598 from 23 others
What the payments were for
- Food & beverage$1,659100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $385 |
| AbbVie | 23 | $270 |
| Astellas Pharma US Inc | 7 | $120 |
| Novartis | 8 | $110 |
| Lilly USA, LLC | 7 | $101 |
| Hologic Sales And Service, LLC | 4 | $76 |
| Pfizer | 4 | $70 |
| Novo Nordisk | 4 | $58 |
| AstraZeneca | 3 | $41 |
| Vertex | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $35 |
| Merck | 2 | $33 |
| Sage Therapeutics, LLC | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Abbott | 2 | $26 |
| Convatec Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Medtronic | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Organon | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Bayer | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$1,659 in reported general payments places this provider in the 80th percentile of 66 women's health providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 48 | $2,663 |
| Clobetasol Propionate | 19 | $629 |
| Oxybutynin Chloride ErOxybutynin Chloride | 22 | $399 |
| Nystatin | 12 | $119 |
| Fluconazole | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other women's health in Laurel
- Sonya EverettLaurel$162
- Casey HerringtonLaurel$27
- Casey HargettTupelo$7K
- Kathryn ElliottOxford$7K
- Jennifer FredricksonSouthaven$6K
- Wanda BrownOlive Branch$4K
- Deborah VerucchiSouthaven$3K
- Daphne HuttoPascagoula$3K
- Felecia BrownMeridian$3K
- Rachel FordJackson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.